A4M Peptide Therapy Module I 2026: Overview
A4M Peptide Therapy Module I 2026 introduces peptide-related signaling and the questions that surround its use in practice. The curriculum covers pharmaceutical quality, sterile manufacturing, evidence and regulatory considerations before moving into metabolic health, immune modulation, tissue repair, hormone signaling and patient cases.
Designed for licensed healthcare practitioners, the module brings together physicians and pharmacists with different clinical perspectives. The faculty and original topic list below outline the teaching content and scheduled session durations.
Purchase scope: Module I is part of a two-module provider certification pathway. This MedicalAmboss file purchase does not provide enrollment in that pathway, membership, provider assessments or certification. Course inclusion does not establish a compound’s approval or clinical suitability.
Official Module I Faculty
The 2026 Module I faculty includes:
- Anthony J. Campbell, PharmD, BCSCP
- Tyler Chamberlain, PharmD, FAPC
- Gordon Crozier, DO
- Marisol Duque, MD
- James LaValle, RPh, CCN, MT, DHM, DHPh
- Stephanie Mazurek, PharmD
- Kathleen O’Neil-Smith, MD, FAARM
- Erika Schwartz, MD
- Christopher Shade, PhD
The multidisciplinary faculty includes physicians, pharmacists, researchers, and clinicians involved in integrative and regenerative medicine education.
Topics
+ Topics:
- Peptides Overview: Controlling Metaflammation, Metabolic Signaling & Clinical Value — 1 hr
- FDA, Quality Assurance & State-to-State Status — 1.5 hr
- Manufacturing of Sterile Product Quality Control — Parts I & II — 2 hrs
- Personalized Peptide Protocols — 0.5 hr
- Integrating Peptides into Clinical Practice — 1 hr
- Global Lifestyle Considerations in Peptide Medicine — 1.5 hr
- SARMs: Science & Controversy — 1 hr
- Body Composition & Metabolism — 2.5 hrs
- Immune Modulation & Gut Repair — 1.5 hr
- Liposomal Oral Peptides — 0.5 hr
- Peptides in Glucose & Insulin Regulation — 1 hr
- Peptides & Bioregulators — 1 hr
- Connective Tissue & Organ Repair — 1.5 hr
- Cellular Senescence, DNA Damage & Telomeres — 1 hr
- Hormone Signaling & Receptor Modulation — 2 hrs
- Brain Inflammation & Autoimmune — 1 hr
- Patient Case Panel — 1 hr
Program Reference and Delivery
Compare the module outline with the official A4M 2026 program. Official enrollment and certification arrangements are separate from the retailer’s files. The scheduled teaching duration is not an independently verified runtime of the delivered package.
Product Summary
Primary Category: Endocrine and Nutrition
Secondary Category: Internal Medicine
Meta Description: A4M Peptide Therapy Module I 2026: review the curriculum, faculty, quality assurance and metabolic topics. Check file delivery and certification terms.



